½ÃÀ庸°í¼­
»óǰÄÚµå
1372871

»ê¼Ò Ä¡·á±â ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø(2018-2028³â) : Á¦Ç° À¯Çüº°, À̵¿¼ºº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀï

Oxygen Therapy Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type, Mobility, By Application, By End User, By Region and Competition

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

2022³â ¼¼°è »ê¼Ò Ä¡·á±â ½ÃÀå ±Ô¸ð´Â 108¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2028³â±îÁö 6.22%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» À¯ÁöÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

»ê¼ÒÄ¡·á´Â ÃæºÐÇÑ »ê¼Ò ³óµµ À¯Áö°¡ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ¸Å¿ì Áß¿äÇÑ Ä¡·á¹ýÀÔ´Ï´Ù. »ê¼Ò ¿ä¹ýÀº õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), ¼ö¸é¹«È£ÈíÁõ µî ȯÀÚ¿¡°Ô »ê¼Ò °ø±Þ ºÎÁ·À» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù.

ȯÀÚ´Â Çʿ信 µû¶ó »ê¼Ò ³óÃà±â, ¾×ü »ê¼Ò, °í¾Ð »ê¼Ò ¿ä¹ý µî ´Ù¾çÇÑ Á¾·ùÀÇ »ê¼Ò ¿ä¹ýÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á °³ÀÔÀ¸·Î¼­ÀÇ »ê¼Ò ¿ä¹ýÀº ±Þ¼º ¶Ç´Â ¸¸¼º ȯÀÚ Ä¡·á¿¡ »ê¼Ò °¡½º¸¦ »ç¿ëÇÏ¿© ´Ù¾çÇÑ ¼¼Æ÷ ´ë»ç °úÁ¤À» Áö¿øÇϰí Á¶Á÷ÀÇ »ê¼ÒÈ­¸¦ ÅëÇØ ÃÖÀûÀÇ »ý¸®Àû ±â´ÉÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

»ê¼Ò¿ä¹ýÀº Ç÷Áß »ê¼Ò ³óµµ°¡ ÇÊ¿äÇÑ ÀÓ°èÄ¡ ÀÌÇÏ·Î ¶³¾îÁ³À» ¶§ ÇÊ¿äÇÕ´Ï´Ù. »ê¼Ò ¿ä¹ýÀº ºñ°­À» ÅëÇÑ ºñ°­ Åõ¿©ºÎÅÍ ¹ÐÆóµÈ ȯ°æ¿¡¼­ ½ÃÇàÇÏ´Â °í¾Ð »ê¼Ò ¿ä¹ý±îÁö ´Ù¾çÇÑ ¹æ¹ýÀ¸·Î ½ÃÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. Æó, ºñ°­, ±â°üÀ¸·Î ±¸¼ºµÈ È£Èí±â´Â È£Èí °úÁ¤À» ÃËÁøÇÕ´Ï´Ù. °ø±â´Â ÄÚ³ª ÀÔÀ» ÅëÇØ ü³»·Î µé¾î°¡ ±â°üÁö¸¦ °ÅÃÄ ±â°üÁö¸¦ ÅëÇØ Æó¿¡ µµ´ÞÇÕ´Ï´Ù. »ê¼Ò Ä¡·á±â´Â »ê¼Ò°¡ ³óÃàµÈ °ø±â¸¦ ¾ÈÁ¤ÀûÀ¸·Î °ø±ÞÇÒ ¼ö ÀÖ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â ÁÖº¯ °ø±â¸¦ È¿°úÀûÀ¸·Î ¿©°úÇÏ°í ¸ÕÁö, ¹ÚÅ׸®¾Æ ¹× ±âŸ ¹Ì¸³ÀÚ¸¦ Á¦°ÅÇÏ¿© °ø±ÞµÇ´Â »ê¼ÒÀÇ ¼øµµ¸¦ º¸ÀåÇÕ´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2024-2028³â
½ÃÀå ±Ô¸ð 108¾ï 3,000¸¸ ´Þ·¯
2028³â ½ÃÀå ±Ô¸ð 156¾ï 3,000¸¸ ´Þ·¯
CAGR 2023-2028³â 6.22%
±Þ¼ºÀå ºÎ¹® ÈÞ´ë¿ë
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

ÃֽŠ»ê¼ÒÄ¡·á ¼Ö·ç¼ÇÀÇ ±ÞÁõ

°¡Àå ÀÛ°í ³»±¸¼ºÀÌ ¶Ù¾î³­ ÈÞ´ë¿ë »ê¼Ò ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ÀÛ°í ¿À·¡ »ç¿ëÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ÈÞ´ë°¡ °£ÆíÇÑ »ê¼Ò Ä¡·á ¿É¼ÇÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼±È£´Â ¹«°Ì°í ¹ø°Å·Î¿î »ê¼Ò ÀåÄ¡¸¦ µé°í ´Ù´Ï´Â ºÎ´ãÀ» ÇÇÇÏ·Á´Â ¿å±¸¿¡¼­ ºñ·ÔµË´Ï´Ù. ´ÙÇེ·´°Ôµµ ÃÖ±Ù ¸î ³â µ¿¾È »ê¼Ò¸¦ Àý¾àÇÏ´Â ¹æ¹ý°ú ¸®Æ¬À̿ ¹èÅ͸® ±â¼úÀÌ Å©°Ô ¹ßÀüÇÏ¿© ƯÈ÷ ¹èÅ͸® ¼ö¸íÀÌ Çâ»óµÇ¾ú½À´Ï´Ù.

´ã¹è Èí¿¬ÀÇ Áõ°¡

Èí¿¬°ú °ü·ÃµÈ °Ç°­ ¹®Á¦´Â Àü ¼¼°èÀûÀ¸·Î °øÁߺ¸°ÇÀÇ ÁÖ¿ä °ü½É»çÀ̱⠶§¹®¿¡ Èí¿¬ÀÇ Áõ°¡´Â »ê¼Ò Ä¡·á±âÀÇ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Èí¿¬Àº ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD)°ú Æó¾ÏÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ È£Èí±â ÁúȯÀÇ ÁÖ¿ä ¿øÀÎÀ̸ç, Ä¡·á ¹× °ü¸® °èȹÀÇ ÀÏȯÀ¸·Î »ê¼Ò ¿ä¹ýÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù.

COPD´Â ÀϹÝÀûÀ¸·Î Èí¿¬°ú °ü·ÃµÈ ÁøÇ༺ Æó ÁúȯÀ¸·Î, È¿À²ÀûÀ¸·Î È£ÈíÇÏ´Â ´É·Â¿¡ ½É°¢ÇÑ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. Áõ»óÀÌ ¾ÇÈ­µÇ¸é »ê¼Ò °áÇÌÀÌ ¹ß»ýÇÏ¿© ÀûÀýÇÑ Ç÷Áß »ê¼Ò ³óµµ¸¦ À¯ÁöÇϱâ À§ÇØ »ê¼Ò º¸Ãæ ¿ä¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. Èí¿¬À¸·Î ÀÎÇÑ COPD ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇØ »ê¼Ò ³óÃà±â, ÈÞ´ë¿ë »ê¼Ò ½Ç¸°´õ ¹× ±âŸ »ê¼Ò °ø±Þ ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Èí¿¬Àº Æó¾ÏÀÇ ½É°¢ÇÑ À§Çè ¿ä¼ÒÀ̸ç, Æó¾Ï Ä¡·á¸¦ ¹Þ´Â ȯÀÚµéÀº Áõ»ó°ú ºÎÀÛ¿ëÀ» °ü¸®Çϱâ À§ÇØ »ê¼Ò ¿ä¹ýÀ» ÇÊ¿ä·Î ÇÒ ¼ö ÀÖ½À´Ï´Ù. Èí¿¬ ½À°üÀ¸·Î ÀÎÇÑ Æó¾Ï ¹ßº´·üÀÌ Àü ¼¼°èÀûÀ¸·Î Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó »ê¼Ò ³óÃà±â ¹× »ê¼Ò ¸¶½ºÅ©¿Í °°Àº »ê¼Ò ¿ä¹ý Àåºñ¿¡ ´ëÇÑ ¼ö¿äµµ ÇÔ²² Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Èí¿¬°ú °ü·ÃµÈ °Ç°­ »óÅÂÀÇ Áõ°¡´Â ȯÀÚ °ü¸®¿Í »ýȰ °³¼±¿¡ »ê¼Ò Ä¡·á±âÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. Èí¿¬°ú °ü·ÃµÈ È£Èí±â ÁúȯÀº Àü ¼¼°èÀûÀ¸·Î Å« °Ç°­ ¹®Á¦°¡ µÇ°í Àֱ⠶§¹®¿¡ »ê¼Ò Ä¡·á±â¿¡ ´ëÇÑ ¼ö¿ä´Â Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ Áß¿äÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀÎ ¹ßÀü°ú Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù.

È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡

È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â »ê¼Ò Ä¡·á±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â Çö´ë ÀÇ·áÀÇ Áß¿äÇÑ Ãø¸éÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä, Æó·Å, °£Áú¼ºÆóÁúȯ°ú °°Àº È£Èí±â ÁúȯÀº Àü ¼¼°èÀûÀ¸·Î Áõ°¡ Ãß¼¼¿¡ ÀÖÀ¸¸ç, Áõ»óÀ» °ü¸®Çϰí ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇØ »ê¼ÒÄ¡·á°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù.

COPD¿Í °°Àº ¸¸¼º È£Èí±â ÁúȯÀº ƯÈ÷ ´ë±â ¿À¿°, Èí¿¬, °í·ÉÈ­ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ °øÁß º¸°Ç¿¡ Å« ¹®Á¦°¡µÇ°í ÀÖÀ¸¸ç, COPD ȯÀÚ´Â Á¾Á¾ È£Èí °ï¶õÀ» °æÇèÇϰí ÀûÀýÇÑ Ç÷Áß »ê¼Ò ³óµµ¸¦ À¯ÁöÇϱâ À§ÇØ º¸Á¶ »ê¼Ò¸¦ ÇÊ¿ä·ÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Áõ°¡·Î ÀÎÇØ »ê¼Ò ³óÃà±â, ÈÞ´ë¿ë »ê¼Ò ½Ç¸°´õ ¹× ±âŸ »ê¼Ò °ø±Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ ÈçÇÑ È£Èí±â ÁúȯÀΠõ½ÄÀº Àü ¼¼°èÀûÀ¸·Î ¼ö¹é¸¸ ¸íÀÌ ¾Î°í ÀÖÀ¸¸ç, ½ÉÇÑ Ãµ½Ä ¹ßÀÛÀº »ê¼Ò °áÇÌÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. õ½Ä ±Þ¼º ¾ÇÈ­ ½Ã ȯÀÚ¸¦ ¾ÈÁ¤½Ã۱â À§Çؼ­´Â »ê¼Ò Ä¡·á°¡ ÇʼöÀûÀÎ °æ¿ì°¡ ¸¹¾Æ »ê¼Ò °ü·Ã Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖÀ¸¸ç, COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ Àü ¼¼°è º´¿øµéÀÌ ½É°¢ÇÑ È£Èí±â Áõ»óÀ» º¸À̴ ȯÀÚ°¡ ±ÞÁõÇÔ¿¡ µû¶ó »ê¼Ò Ä¡·á±âÀÇ Á߿伺ÀÌ ´õ¿í ºÎ°¢µÇ¾ú½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ÀÇ·á ½Ã¼³¿¡ ÃæºÐÇÑ »ê¼Ò ÀÎÇÁ¶ó¸¦ ±¸ÃàÇØ¾ß ÇÒ Çʿ伺ÀÌ °­Á¶µÇ¸é¼­ »ê¼Ò ³óÃà±â ¹× ÀΰøÈ£Èí±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í °­Á¶µÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, ÀÇ·á Æ®·»µå°¡ ÀçÅÃÀÇ·á¿Í ¿ø°ÝÀÇ·á·Î ÀüȯµÊ¿¡ µû¶ó Áý¿¡¼­ ¸¸¼º È£Èí±â ÁúȯÀ» °ü¸®Çϴ ȯÀÚµéÀ» À§ÇØ ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î »ê¼Ò Ä¡·á±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

»ê¼Ò Ä¡·áÀÇ ±â¼ú ¹ßÀü

»ê¼Ò Ä¡·á ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº ÇコÄÉ¾î »ê¾÷¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ »ê¼Ò Ä¡·á±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Àü·Ê ¾øÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº Ä¡·á È¿°ú¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚÀÇ ÆíÀǼº°ú Á¢±Ù¼ºÀ» Çâ»ó½ÃÄÑ È£Èí±â Ä¡·áÀÇ Àü¸ÁÀ» À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

Áß¿äÇÑ ¹ßÀü Áß Çϳª´Â ȯÀÚ°¡ À̵¿ Áß¿¡µµ ÀÚÀ¯·Ó°Ô »ê¼Ò Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ´Â ÈÞ´ë¿ë »ê¼Ò ³óÃà±â(POC)ÀÇ º¸±ÞÀÔ´Ï´Ù. ÀÌ °¡º±°í ÄÄÆÑÆ®ÇÑ ÀåÄ¡´Â ÷´Ü ¹èÅ͸® ±â¼úÀ» žÀçÇØ Àå½Ã°£ ÀÛµ¿ÇÒ ¼ö ÀÖ¾î ȯÀÚ°¡ Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» À¯ÁöÇÒ ¼ö ÀÖ¾î »îÀÇ Áú Çâ»ó¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸°¡ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ³ëÀεéÀÌ ÀÚ¸³Çϰí Áö¿ª»çȸ¿¡ °è¼Ó Âü¿©ÇÒ ¼ö ÀÖµµ·Ï µ½´Â POC¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀº »ê¼Ò Ä¡·á °ü¸®ÀÇ °­·ÂÇÑ µµ±¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¼¾¼­¿Í ¹«¼± ¿¬°áÀÇ ÅëÇÕÀ» ÅëÇØ ÀÇ·á Àü¹®°¡´Â ¿ø°ÝÀ¸·Î ȯÀÚÀÇ »ê¼Ò ³óµµ¸¦ ÃßÀûÇϰí, Ä¡·á °èȹÀ» ½Ç½Ã°£À¸·Î Á¶Á¤Çϰí, ÇÊ¿äÇÑ °æ¿ì Áï°¢ÀûÀÎ Áö¿øÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ȯÀÚÀÇ Àü¹ÝÀûÀΠü°¨µµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á ½Ã¼³°ú Á÷¿øÀÇ ºÎ´ãÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå °úÁ¦

¾ö°ÝÇÑ ±ÔÁ¦ °¡À̵å¶óÀÎ

ÇコÄÉ¾î »ê¾÷ÀÇ ¾ö°ÝÇÑ ±ÔÁ¦ ÁöħÀº »ê¼Ò Ä¡·á±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦´Â ȯÀÚÀÇ ¾ÈÀü°ú Ä¡·á È¿°ú¸¦ º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÌÁö¸¸ Áö³ªÄ¡°Ô º¹ÀâÇÏ°í ºÎ´ã½º·¯¿î ±ÔÁ¦ ȯ°æÀº ±â¼ú Çõ½ÅÀ» ¹æÇØÇÏ°í ºñ¿ëÀ» ³ôÀ̰í Á¦Á¶¾÷ü¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ½ÃÀå ÁøÀÔÀ» Á¦ÇÑÇÏ´Â Àå¾Ö¹°À» ¸¸µé ¼ö ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·Î¼¼½º´Â »õ·Ó°í °³¼±µÈ »ê¼Ò Ä¡·á±âÀÇ ½ÃÀå Ãâ½Ã¸¦ Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¿¬Àº ½É°¢ÇÑ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖÀ¸¸ç, ȯÀÚµéÀº º¸´Ù È¿°úÀûÀÎ Ä¡·á¿Í »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ±â¼ú Çõ½ÅÀ» ¹ÞÁö ¸øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀο¡ µû¸¥ ºÒÈ®½Ç¼º°ú º¹À⼺À¸·Î ÀÎÇØ ½Å±â¼ú äÅÃÀ» ÁÖÀúÇÏ¿© ¼ö¿ä¸¦ ´õ¿í ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀº »ç¿ë °¡´ÉÇÑ ÀåºñÀÇ ¼±ÅñÇÀ» Á¦ÇÑÇÏ°í ¾÷°è ³» °æÀï°ú Çõ½ÅÀ» °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¾ç¼º ºÎÁ·Àº ȯÀÚ¿Í ÀÇ·á Àü¹®°¡¿¡°Ô ¼±ÅÃÀÇ ÆøÀ» Á¼ÇôÁÖ°í, °³º°ÀûÀÎ ¿ä±¸¿¡ °¡Àå ÀûÇÕÇÑ ¼Ö·ç¼ÇÀ» ã´Â °ÍÀ» ¾î·Æ°Ô ¸¸µì´Ï´Ù. ±ÔÁ¦ °¡À̵å¶óÀÎÀº ȯÀÚÀÇ ¾ÈÀü°ú Ä¡·á È¿°ú¸¦ º¸ÀåÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÏÁö¸¸, Áö³ªÄ¡°Ô ¾ö°ÝÇÑ ±ÔÁ¦´Â »ê¼Ò Ä¡·á±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¨¼Ò½ÃŰ´Â À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦¿Í ±â¼ú Çõ½Å »çÀÌÀÇ ÀûÀýÇÑ ±ÕÇüÀ» ¸ÂÃß´Â °ÍÀº ȯÀÚ°¡ °¡Àå Áøº¸µÇ°í Àú·ÅÇÑ È£Èí Ä¡·á ¼Ö·ç¼ÇÀ» ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ºó¹ßÇÏ´Â ºÎÀÛ¿ë

»ê¼Ò¿ä¹ýÀÇ ½ÃÀå È®´ë´Â Ä¡·á ¸ñÀûÀ¸·Î »ç¿ëµÉ ¶§ ÇǺΠÀڱذú ÄÚ °ÇÁ¶¿Í °°Àº ¹Ù¶÷Á÷ÇÏÁö ¾ÊÀº ºÎÀÛ¿ëÀ¸·Î ÀÎÇØ Á¦ÇÑÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÄÚ °ÇÁ¶¿Í ÇǺΠ¿°ÁõÀº »ê¼Ò ¿ä¹ýÀÇ °¡Àå ÀϹÝÀûÀÎ ºÎÀÛ¿ë Áß µÎ °¡ÁöÀÔ´Ï´Ù. ij´¼¶ó°¡ ÇÇºÎ¿Í ¸¶ÂûÇÏ¿© ¿°ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, °í³óµµ »ê¼Ò¿¡ Àå½Ã°£ ³ëÃâµÇ¸é »ê¼Ò Áßµ¶ÀÇ À§ÇèÀÌ ³ô¾ÆÁ® Æó»Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ Àå±â ½Ã½ºÅÛ¿¡µµ ½É°¢ÇÑ ÇØ¸¦ ³¢Ä¥ ¼ö ÀÖ½À´Ï´Ù. ºÎÀûÀýÇÑ »ê¼Ò °ø±ÞÀ̳ª °úµµÇÑ »ê¼Ò °ø±ÞÀº »ê¼Ò Áßµ¶À» À¯¹ßÇÏ¿© Æó ±â´É°ú Àü½Å °Ç°­¿¡ ¾Ç¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â Æó ¼Õ»óÀ¸·Î À̾îÁú ¼ö ÀÖÀ¸¸ç ½ÅüÀÇ È¿°úÀûÀÎ °¡½º ±³È¯ ´É·ÂÀ» ¼Õ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, »ê¼Ò ¿ä¹ýÀ¸·Î À¯¹ßµÇ´Â Æó ÁúȯÀÇ ¹üÀ§´Â °¡º­¿î ±â°üÁö ±â°üÁö¿°¿¡¼­ ±¤¹üÀ§ÇÑ ÆóÆ÷ ¼Õ»ó¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù. °í³óµµ »ê¼Ò¿¡ Àå±â°£ ³ëÃâµÇ¾î ¹ß»ýÇϴ Ȱ¼º»ê¼ÒÀÇ °úÀ× »ý¼ºÀº Æó ¼Õ»óÀÇ ¿øÀÎÀÌ µÇ¾î »ê¼Ò ¿ä¹ýÀÇ Àü¹ÝÀûÀÎ È¿°ú¸¦ ¹æÇØÇÕ´Ï´Ù.

ÀÌ·¯ÇÑ ¿äÀεéÀ» °í·ÁÇϸé, »ê¼Ò Ä¡·á¿Í °ü·ÃµÈ ÀÌ·¯ÇÑ ºÎÀÛ¿ë°ú ÀáÀçÀû À§ÇèÀÇ Á¸Àç´Â »ê¼Ò Ä¡·á±â ½ÃÀå È®´ë¿¡ µµÀüÀÌ µÉ ¼ö ÀÖ´Ù´Â °ÍÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ

Ä¡·á ±â±âÀÇ ±â¼ú¹ßÀü

»ê¼Ò Ä¡·á±â(OTD)¿¡ ÀÇÁ¸Çϴ ȣÈí±â Áúȯ ȯÀÚ ¼ö°¡ Å©°Ô Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ±â°üÀº »ê¼Ò Ä¡·á±â Áö¿øÀ» ÇÊ¿ä·Î Çϴ ȯÀÚµéÀ» È¿°úÀûÀ¸·Î °ü¸®ÇØ¾ß ÇÑ´Ù´Â ¾Ð¹Ú¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡´Â »ê¼Ò Ä¡·á ¼Ö·ç¼Ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â¼úÀÌ °è¼Ó ¹ßÀüÇÏ°í ±¤Àü ¿ëÀû ¸ÆÆÄ(PPG) ¼¾¼­¿Í ¹«¼± 5G ¿¬°áÀÌ ´«¿¡ ¶ç°Ô °³¼±µÊ¿¡ µû¶ó »ê¼Ò ¿ä¹ý ¸ð´ÏÅ͸µÀ» À§ÇÑ **µðÁöÅÐ Çコ** µ¥ÀÌÅÍ Àü¼ÛÀÇ Ãß¼¼´Â ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

PPG´Â ºñħ½ÀÀûÀÎ ÀåÄ¡·Î, ÇǺΠǥ¸é¿¡ ¹èÄ¡µÈ ±¤¿ø°ú ±¤ °ËÃâ±â¸¦ ÀÌ¿ëÇØ Ç÷¾× ¼øÈ¯ÀÇ ºÎÇÇ º¯È­¸¦ Á¤È®ÇÏ°Ô ÃøÁ¤ÇÕ´Ï´Ù. ¿þ¾î·¯ºí PPG ¼¾¼­´Â ¼Õ³¡, ±ÓºÒ, À̸¶ µî ½ÅüÀÇ Æ¯Á¤ ºÎÀ§¿¡ Æí¾ÈÇÏ°Ô Âø¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ »ç¿ë°ú µµÀÔÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ȯÀÚµéÀº ÀÌ·¯ÇÑ ½Ã½ºÅÛ »ç¿ë¿¡ ´ëÇÑ ÀûÀýÇÑ Áöħ ´öºÐ¿¡ ÀÚ½ÅÀÇ Ä¡·á¿¡ ´õ Àû±ØÀûÀ¸·Î Âü¿©ÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀü°ú ȯÀÚ Âü¿©´Â ½ÃÀå ¼ºÀå°ú ¼öÀͼº¿¡ ´ëÇÑ À¯¸ÁÇÑ Àü¸ÁÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù.

÷´Ü ÈÞ´ëÇü »ê¼Ò ¼Ö·ç¼Ç

ÈÞ´ë¿ë »ê¼Ò ³óÃà±â(POC)¿Í °æ·®È­ ¹× Âø¿ë °¡´ÉÇÑ ±â±â´Â ¾ÕÀ¸·Îµµ °è¼Ó ¹ßÀüÇÒ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ȯÀÚµéÀº Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» À¯ÁöÇϸ鼭 »ê¼ÒÄ¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ°í, ¿©Ç൵ ÇÒ ¼ö ÀÖ°Ô µÇ¾î »îÀÇ Áú Çâ»ó¿¡ ±â¿©ÇÒ °ÍÀ̸ç, POC´Â ´õ¿í ÀÛ°í °¡º­¿öÁ® È޴뼺ÀÌ Çâ»óµÉ °ÍÀÔ´Ï´Ù. ÀÌ ÀåºñµéÀº ¹è³¶¿¡ ³Ö°í ´Ù´Ï°Å³ª ´«¿¡ Àß ¶çÁö ¾Ê´Â ¾×¼¼¼­¸®·Î Âø¿ëÇÒ ¼ö ÀÖ°Ô µÉ °ÍÀÔ´Ï´Ù. ȯÀÚµéÀº ºÎÇǰ¡ Å« Àåºñ¿¡ ¾ô¸ÅÀÌÁö ¾Ê°í ÀÚÀ¯·Ó°Ô ¿òÁ÷ÀÏ ¼ö ÀÖ°Ô µÉ °ÍÀÔ´Ï´Ù.

¹èÅ͸® ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó POCÀÇ ±¸µ¿ ½Ã°£ÀÌ ±æ¾îÁö°í ÀÖ½À´Ï´Ù. À̴ ȯÀÚ°¡ ÃæÀüÀ̳ª ¹èÅ͸® ±³Ã¼ ¾øÀÌ Àå½Ã°£ »ç¿ëÇÒ ¼ö ÀÖ´Ù´Â °ÍÀ» ÀǹÌÇϸç, ¿©ÇàÀ̳ª ¾ß¿Ü Ȱµ¿À» ´õ¿í ½Ç¿ëÀûÀ¸·Î ¸¸µé ¼ö ÀÖÀ¸¸ç, POC¿¡ ¹«¼± ¿¬°á ¿É¼ÇÀÌ ÀåÂøµÇ¾î ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ¹× °£º´ÀÎÀÌ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. »ê¼Ò ¼öÁذú »ç¿ë ÆÐÅÏ¿¡ ´ëÇÑ µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î Àü¼ÛÇÒ ¼ö Àֱ⠶§¹®¿¡ Ä¡·á °èȹÀ» Àû½Ã¿¡ Á¶Á¤ÇÏ°í ´õ ³ªÀº Áö¿øÀ» Á¦°ø ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ» ÅëÇØ ȯÀÚµéÀº »ê¼Ò Ä¡·áÀÇ Çʿ並 °ü¸®Çϸ鼭 º¸´Ù Ȱµ¿ÀûÀ̰í Ãæ¸¸ÇÑ »îÀ» ¿µÀ§ÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù. Çâ»óµÈ È޴뼺, ÆíÀǼº ¹× ¿¬°á¼ºÀ» ÅëÇØ ȯÀڴ Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» À¯ÁöÇÏ°í ¿©Çà ¹× ´Ù¾çÇÑ È°µ¿¿¡ Âü¿©ÇÒ ¼ö ÀÖÀ¸¸ç ±Ã±ØÀûÀ¸·Î È£Èí±â Áúȯ ȯÀÚÀÇ »îÀÇ Áú Çâ»ó¿¡ ±â¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºÎ¹®º° ÀλçÀÌÆ®

¸ðºô¸®Æ¼ÀÇ ÀλçÀÌÆ®

À̵¿¼º ºÎ¹®À» ±âÁØÀ¸·Î º¼ ¶§, °íÁ¤½Ä »ê¼Ò Ä¡·á±â´Â À̵¿¼º Ãø¸é¿¡¼­ ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÁÖ·Î Ä¡·á¸¦ ¹Þ´Â ȯÀÚÀÇ »ó´ç¼ö°¡ ħ´ë¿¡ °¤Çô Àֱ⠶§¹®¿¡ °íÁ¤½Ä »ê¼Ò Ä¡·á±â ½ÃÀåÀÌ ÁÖ¿ä °ßÀÎÂ÷ ¿ªÇÒÀ» ÇÏ¸ç ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼öÀÍÀ» ±Ø´ëÈ­ÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ Ä«Å×°í¸®ÀÇ È®´ë´Â Àα¸ ±â¹Ý Áõ°¡, À¯¸®ÇÑ »óȯ Á¤Ã¥, ȯÀÚÀÇ ³·Àº À̵¿¼º µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ±× °á°ú, ÁְŠȯ°æ¿¡¼­ Àå±â »ê¼Ò ¿ä¹ý(LTOT) Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È Àüü »ê¼Ò ¿ä¹ý Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁְŠȯ°æ¿¡¼­ LTOT ÀåºñÀÇ »ç¿ëÀº ȯÀÚ¿¡°Ô Æí¸®ÇÔ°ú Æí¾ÈÇÔÀ» Á¦°øÇÒ »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚÀÇ Àü¹ÝÀûÀÎ »îÀÇ Áú Çâ»ó¿¡µµ ±â¿©ÇÕ´Ï´Ù.

¿ëµµº° ÀλçÀÌÆ®

¿ëµµº°·Î´Â ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), Æó¾Ï, Æó·Å, COVID-19, ±âŸ·Î ³ª´¹´Ï´Ù. ÀÌ Áß ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD) ºÐ¾ß´Â Àü ¼¼°èÀûÀ¸·Î COPD À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ Ã߻꿡 µû¸£¸é, ÇöÀç ¾à 6,500¸¸ ¸íÀÌ COPD¸¦ ¾Î°í ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è 5À§ »ç¸Á¿øÀÎÀÔ´Ï´Ù. ÀÌ ³î¶ó¿î Åë°è´Â È¿°úÀûÀÎ COPD Ä¡·á¿¡ ´ëÇÑ ½Ã±ÞÇÑ Çʿ伺À» °­Á¶Çϸç, ½ÃÀå¿¡ Å« ÀÓ»óÀû ¼ö¿ä¸¦ âÃâÇϰí ÀÌ ºÐ¾ß¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ±â¾÷µéÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀÇ °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â ¼¼°è »ê¼Ò Ä¡·á±â ½ÃÀå¿¡¼­ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â COPD, õ½Ä, ÀÏ»êȭź¼Ò Áßµ¶°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ COVID-19 È®ÁøÀÚ ¼ö Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È »ê¼Ò Ä¡·á±â ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¹Ì±¹Àº ¼¼°è »ê¼Ò Ä¡·á±â ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ±× ÁÖ¿ä ÀÌÀ¯´Â ÀÇ·á ÀÎÇÁ¶ó°¡ Àß ±¸ÃàµÇ¾î ÀÖ°í ÷´Ü ºñħ½ÀÀû ȯÀÚ ¸ð´ÏÅ͸µ ±â¼úÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc. µîÀÇ ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç´Â »ê¼Ò Ä¡·á±â ½ÃÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì »ê¼Ò Ä¡·á±â ½ÃÀåÀº ¹æ´ëÇÑ È¯ÀÚ Àα¸¿Í ÀÌ Áö¿ªÀÇ ½ÅÁ¦Ç° Ãâ½Ã µî ´Ù¾çÇÑ ¿äÀÎÀ» °í·ÁÇÒ ¶§ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå »ê¼Ò Ä¡·á±â ¼¼°è ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°(»ê¼Ò¿ø Àåºñ/»ê¼Ò °ø±Þ Àåºñ)
    • À̵¿¼ºº°(°íÁ¤Çü/ÈÞ´ëÇü)
    • ¿ëµµº°(COPD, Æó¾Ï, Æó·Å, COVID-19, ±âŸ)
    • ÃÖÁ¾»ç¿ëÀÚº°(º´¿ø¡¤Å¬¸®´Ð, ¿Ü·¡ ÀÇ·á ¼¾ÅÍ, ÀçÅÃÀÇ·á, ±âŸ)
    • Áö¿ªº°
    • ±â¾÷º°(2022³â)
  • ½ÃÀå ¸Ê

Á¦6Àå ºÏ¹ÌÀÇ »ê¼Ò Ä¡·á±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¸ðºô¸®Æ¼º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ºÏ¹Ì ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦7Àå À¯·´ »ê¼Ò Ä¡·á±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¸ðºô¸®Æ¼º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • À¯·´ ±¹°¡º° ºÐ¼®
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ê¼Ò Ä¡·á±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¸ðºô¸®Æ¼º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ

Á¦9Àå ³²¹Ì »ê¼Ò Ä¡·á±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¸ðºô¸®Æ¼º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »ê¼Ò Ä¡·á±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¸ðºô¸®Æ¼º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • MEA : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÃÖ±ÙÀÇ Àü°³
  • ÀμöÇÕº´
  • Á¦Ç° ¹ßÇ¥

Á¦13Àå ¼¼°èÀÇ »ê¼Ò Ä¡·á±â ½ÃÀå SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

  • ¾÷°è³» °æÀï
  • ½Å±Ô Âü¿© °¡´É¼º
  • °ø±Þ¾÷üÀÇ ´É·Â
  • °í°´ÀÇ ´É·Â
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °æÀï »óȲ

  • Business Overview
  • Service Offerings
  • Recent Developments
  • Key Personnel
  • SWOT Analysis
    • Allied Healthcare Products, Inc.
    • CAIRE Inc.
    • DeVilbiss Healthcare
    • Fisher & Paykel Healthcare Limited
    • Inogen Inc.
    • Invacare Corporation
    • Koninklijke Philips N.V.,
    • Smiths Medical, Inc.
    • Taiyo Nippon Sanso Corporation
    • Linde Healthcare

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm 23.11.09

In 2022, the Global Oxygen Therapy Equipment Market reached a valuation of USD 10.83 Billion, and it is poised to exhibit impressive growth during the forecast period, maintaining a substantial Compound Annual Growth Rate (CAGR) of 6.22% through 2028. Oxygen therapy stands as a pivotal treatment approach for individuals in need of maintaining adequate oxygen levels. It is commonly employed in the management of conditions such as asthma, Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and other scenarios characterized by insufficient oxygen supply to patients.

Patients can access various types of oxygen therapy based on their specific requirements, including oxygen concentrators, liquid oxygen, and hyperbaric oxygen therapy. Oxygen therapy, as a medical intervention, harnesses oxygen gas to administer acute or chronic patient care, playing a critical role in supporting diverse cellular metabolic processes and promoting optimal physiological function through tissue oxygenation.

Oxygen therapy becomes necessary when blood oxygen levels are below the required threshold. It can be administered through a range of methods, encompassing nasal delivery to hyperbaric oxygen therapy conducted within a closed environment. The respiratory system, comprising the lungs, nasal passages, and windpipe, facilitates the process of respiration. Air enters the body through the nose or mouth and travels through the windpipe, reaching the lungs via the bronchi. Oxygen therapy equipment serves as a dependable device that ensures a consistent supply of oxygen-enriched air. These devices effectively filter ambient air, removing dust, bacteria, and other particulates, thereby ensuring the purity of the delivered oxygen.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 10.83 Billion
Market Size 2028USD 15.63 Billion
CAGR 2023-20286.22%
Fastest Growing SegmentPortable
Largest MarketNorth America

Key Market Drivers

Surge In the Latest Oxygen Therapy Solutions

The demand for the most minor, durable portable oxygen solutions is rising. Patients are increasingly seeking oxygen therapy options that are not only compact and long-lasting but also easy to carry. This preference arises from their desire to avoid the burden of lugging around a heavy and cumbersome oxygen device. Fortunately, recent years have witnessed significant advancements in oxygen-conserving methods and lithium-ion battery technology, particularly in terms of battery life improvement.

The latest versions of portable oxygen concentrators weigh a mere 5-7 pounds. These lightweight devices can provide oxygen therapy for extended periods, ranging from 8 to 13 hours, depending on the litre flow settings chosen by each patient, after a single battery charge. The focus of manufacturers has also shifted towards developing silent compressor motors for these concentrators, thereby reducing noise pollution in small and confined spaces.

Moreover, the effective utilization of dosing technology has enabled portable oxygen concentrator manufacturers to enhance their products' performance features. This, in turn, has resulted in current designs that offer a longer lifespan beyond occasional use, making them more reliable and durable for a consistent five-year cycle. With these advancements and improvements, patients can now enjoy the benefits of portable oxygen therapy without compromising on convenience, reliability, and longevity.

Increase in Tobacco Smoking

The increase in tobacco smoking is expected to drive up the demand for oxygen therapy equipment, as smoking-related health issues continue to be a major public health concern worldwide. Smoking is a leading cause of various respiratory conditions, including chronic obstructive pulmonary disease (COPD) and lung cancer, which often necessitate oxygen therapy as part of the treatment and management plan.

COPD, a progressive lung disease commonly linked to smoking, can severely impact a person's ability to breathe efficiently. As the condition worsens, individuals often experience oxygen deficiency, requiring supplemental oxygen therapy to maintain adequate blood oxygen levels. With the rising number of COPD cases due to smoking, there is a growing need for oxygen concentrators, portable oxygen tanks, and other oxygen delivery systems to improve the quality of life for affected individuals.

Moreover, smoking is a significant risk factor for lung cancer, and patients undergoing lung cancer treatments may also require oxygen therapy to manage symptoms and side effects. As the global incidence of lung cancer continues to rise due to smoking habits, the demand for oxygen therapy equipment, such as oxygen concentrators and oxygen masks, is likely to increase in tandem. The increase in tobacco smoking-related health conditions underscores the vital role that oxygen therapy equipment plays in managing and improving the lives of affected individuals. As smoking-related respiratory diseases continue to pose a significant global health challenge, the demand for oxygen therapy equipment is expected to grow, necessitating ongoing advancements and innovations in this critical medical field.

Rising Prevalence of Respiratory Diseases

The rising prevalence of respiratory diseases is expected to drive a significant increase in the demand for oxygen therapy equipment, marking a crucial facet of modern healthcare. Respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and interstitial lung diseases are on the rise globally, and they often necessitate the use of oxygen therapy to manage symptoms and improve patients' quality of life.

Chronic respiratory conditions like COPD have become a major public health concern, particularly due to factors such as air pollution, smoking, and an aging population. Patients with COPD often experience difficulty in breathing and require supplemental oxygen to maintain adequate blood oxygen levels. This growing demographic has led to an increased demand for oxygen concentrators, portable oxygen tanks, and other oxygen delivery systems.

Asthma, another common respiratory ailment, affects millions of people worldwide, and severe asthma attacks can lead to oxygen deprivation. Oxygen therapy is often crucial in stabilizing patients during acute asthma exacerbations, further contributing to the demand for oxygen-related equipment. The COVID-19 pandemic also highlighted the importance of oxygen therapy equipment as hospitals worldwide faced surges in patients with severe respiratory symptoms. This emphasized the necessity for having adequate oxygen infrastructure in healthcare facilities, further underscoring the demand for oxygen concentrators and ventilators.

Furthermore, as healthcare trends shift towards home-based care and telemedicine, the demand for portable and user-friendly oxygen therapy equipment for patients managing chronic respiratory conditions at home is increasing.

Technological Advancement in Oxygen Therapy

Technological advancements in the field of oxygen therapy are poised to revolutionize the healthcare industry, driving an unprecedented surge in the demand for oxygen therapy equipment. These innovations are not only improving the efficacy of treatment but also enhancing patient comfort and accessibility, thus reshaping the landscape of respiratory care.

One significant development is the proliferation of portable oxygen concentrators (POCs) that offer patients the freedom to receive oxygen therapy while on the move. These lightweight and compact devices are equipped with advanced battery technology, ensuring extended runtime, and they allow patients to maintain an active lifestyle, contributing to an increased quality of life. As the aging population continues to grow, the demand for POCs is expected to soar, as they enable seniors to remain independent and engaged in their communities.

Moreover, telemedicine and remote monitoring solutions have emerged as powerful tools in oxygen therapy management. The integration of smart sensors and wireless connectivity enables healthcare professionals to remotely track patients' oxygen levels, adjust treatment plans in real-time, and provide immediate support when necessary. This not only enhances the overall patient experience but also reduces the burden on healthcare facilities and staff.

Key Market Challenges

Stringent Regulatory Guidelines

Stringent regulatory guidelines in the healthcare industry have the potential to significantly decrease the demand for oxygen therapy equipment. While regulations are essential for ensuring patient safety and treatment efficacy, an excessively complex or burdensome regulatory environment can create obstacles that hinder innovation, drive up costs, and limit market access for manufacturers and healthcare providers. Rigorous regulatory processes can slow down the introduction of new and improved oxygen therapy equipment to the market. This delay can have serious consequences, as patients may miss out on potentially more effective treatments or innovations that enhance their quality of life. Healthcare providers may also be discouraged from adopting new technologies due to the uncertainties and complexities associated with regulatory approval, further stifling demand.

Additionally, stringent guidelines can lead to a limited selection of available equipment, reducing competition and innovation within the industry. This lack of variety can result in fewer options for patients and healthcare professionals, making it harder to find solutions that best meet individual needs. While regulatory guidelines are crucial for ensuring patient safety and treatment effectiveness, excessively stringent regulations can create barriers that diminish the demand for oxygen therapy equipment. Striking the right balance between regulation and innovation is essential to ensure that patients have access to the most advanced and affordable respiratory care solutions.

Frequent Adverse Effects

The market expansion for oxygen treatment is being constrained by their unfavorable side effects, which, when used therapeutically, include skin irritation and nasal dryness. Dryness of the nose and skin irritation are two of the most typical side effects of oxygen therapy. The cannula may rub against the skin and create irritation.

Moreover, prolonged exposure to high oxygen concentrations can lead to an increased risk of oxygen toxicity, which can seriously harm not only the lungs but also other organ systems. Inappropriate or excessive supplemental oxygen can result in oxygen toxicity, causing detrimental effects on lung function and overall health. This can potentially lead to lung injury and impair the body's ability to effectively exchange gases.

Additionally, the range of lung ailments that can be induced by oxygen therapy extends beyond minor tracheobronchitis to include widespread alveolar damage. The excessive production of free radicals due to long-term exposure to high oxygen concentrations can further contribute to lung injury and hinder the overall effectiveness of oxygen therapy.

Considering these factors, it becomes evident that the presence of such side effects and potential risks associated with oxygen therapy may pose challenges in the expansion of the oxygen therapy equipment market.

Key Market Trends

Technology Advancements in Therapeutic Equipment

Due to the significant increase in the number of individuals with respiratory conditions who rely on oxygen therapy devices (OTD), healthcare facilities are facing immense pressure to effectively manage patients who require constant OTD support. This growing demand is driving the market for oxygen therapy solutions. As wearable technology continues to advance, with notable improvements in Photoplethysmography (PPG) sensors and wireless 5G connectivity, it is expected that the trend of **digital health** data transfer for oxygen therapy monitoring will experience rapid growth.

PPG, a non-invasive device, accurately measures volumetric fluctuations in blood circulation by utilizing a light source and a photodetector placed on the skin's surface. Wearable PPG sensors can be comfortably accommodated on specific body parts such as fingertips, earlobes, and the forehead. Moreover, with the increasing utilization and adoption of remote patient monitoring systems, patients are becoming more actively engaged in their own care, thanks to proper instruction in the use of these systems. These advancements and patient involvement hold promising prospects for the market's growth and profitability.

Advanced Portable Oxygen Solutions

Portable oxygen concentrators (POCs) and lightweight, wearable devices will continue to evolve. These innovations will allow patients to receive oxygen therapy while maintaining an active lifestyle and even traveling, contributing to a better quality of life. POCs will continue to become smaller and lighter, making them highly portable. These devices will be easier to carry in backpacks or even wear as discreet accessories. Patients will have the freedom to move around without the burden of bulky equipment.

Battery technology will advance, providing POCs with longer runtime. This means patients can go longer periods without needing to recharge or replace their batteries, making travel and outdoor activities more practical. POCs will feature wireless connectivity options, allowing for remote monitoring by healthcare providers and caregivers. Real-time data on oxygen levels and usage patterns can be transmitted, enabling timely adjustments to treatment plans and better support. These advancements will collectively empower patients to lead more active and fulfilling lives while managing their oxygen therapy needs. With greater portability, convenience, and connectivity, patients will be better equipped to maintain an active lifestyle, travel, and participate in a wide range of activities, ultimately contributing to an improved quality of life for individuals with respiratory conditions.

Segmental Insights

Mobility Insights

Based on the mobility segment, the stationary oxygen therapy equipment devices is projected to dominate the market in terms of portability. This is primarily due to the fact that a significant number of patients receiving treatment are confined to beds, thus making the fixed oxygen therapy equipment market the key driver and contributor to maximum market revenue throughout the projection period.

The expansion of this category can be attributed to several factors, including a rising population base, favourable reimbursement policies, and a low mobility profile of patients. As a result, there is an increased demand for long-term oxygen therapy (LTOT) equipment in residential settings, which is expected to further boost the overall demand for oxygen therapy equipment over the projected period. The utilization of LTOT equipment in residential settings not only provides enhanced convenience and comfort for patients but also contributes to the overall improvement in their quality of life.

Application Insights

Based on the Application, the market is bifurcated into Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Pneumonia, COVID-19, and others. Among these, the Chronic Obstructive Pulmonary Disorder (COPD) segment dominates the market with the largest share, owing to the increasing prevalence of COPD worldwide. According to estimates by the World Health Organization (WHO), approximately 65 million individuals are currently suffering from COPD, making it the fifth-leading cause of death globally. This alarming statistic highlights the urgent need for effective COPD therapy and creates a significant clinical demand in the market, which in turn contributes to the growth of companies operating in this domain. With the rising prevalence of COPD, there is an increasing focus on developing innovative treatment solutions to address this chronic respiratory disorder and improve the quality of life for affected individuals.

Regional Insights

During the forecast period, North America is anticipated to maintain its dominance in the global oxygen therapy equipment market. This is attributed to the increasing prevalence of respiratory diseases like COPD, asthma, and carbon monoxide poisoning. Additionally, the rising number of Covid-19 cases in the region is expected to drive the demand for oxygen therapy equipment in the coming years.

Moreover, the United States holds the largest share in the global oxygen therapy equipment market, mainly due to its well-established healthcare infrastructure and the growing adoption of advanced non-invasive patient monitoring technologies. Furthermore, the presence of key market players such as Koninklijke Philips N.V., Invacare Corporation, and Inogen, Inc. is expected to further propel the oxygen therapy equipment market.

Considering various factors, including a sizable patient population and the introduction of new products in the region, the North American oxygen therapy equipment market is projected to witness significant growth during the forecast period.

Key Market Players

  • Allied Healthcare Products, Inc.
  • CAIRE Inc.
  • DeVilbiss Healthcare
  • Fisher & Paykel Healthcare Limited
  • Inogen Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.,
  • Smith's Medical, Inc.
  • Taiyo Nippon Sanso Corporation
  • Linde Healthcare

Report Scope:

In this report, the Global Oxygen Therapy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oxygen Therapy Equipment Market, By Product Type:

  • Oxygen Source Equipment
  • Oxygen Delivery Devices

Oxygen Therapy Equipment Market, By Mobility:

  • Stationary
  • Portable

Oxygen Therapy Equipment Market, By Application:

  • COPD
  • Lung Cancer
  • Pneumonia
  • COVID-19
  • Others

Oxygen Therapy Equipment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centres
  • Homecare
  • Others

Oxygen Therapy Equipment Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Oxygen Therapy Equipment Market.

Available Customizations:

  • Global Oxygen Therapy Equipment market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oxygen Therapy Equipment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Oxygen Source Equipment v/s Oxygen Delivery Devices)
      • 5.2.1.1. By Oxygen Source Equipment (Oxygen Cylinders, Oxygen Concentrators, Liquid Oxygen Devices, Others)
      • 5.2.1.2. By Oxygen Delivery Devices (Oxygen Masks, Nasal Cannula, Non-Rebreather Masks, Others)
    • 5.2.2. By Mobility (Stationary v/s Portable)
    • 5.2.3. By Application (COPD, Lung Cancer, Pneumonia, COVID-19, Others)
    • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map

6. North America Oxygen Therapy Equipment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Mobility
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oxygen Therapy Equipment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Mobility
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Oxygen Therapy Equipment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Mobility
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Oxygen Therapy Equipment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Mobility
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Oxygen Therapy Equipment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Mobility
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oxygen Therapy Equipment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Mobility
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Oxygen Therapy Equipment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Mobility
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Oxygen Therapy Equipment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Mobility
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. France Oxygen Therapy Equipment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Mobility
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Oxygen Therapy Equipment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Mobility
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Oxygen Therapy Equipment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Mobility
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Oxygen Therapy Equipment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Mobility
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Oxygen Therapy Equipment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Mobility
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Oxygen Therapy Equipment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Mobility
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Oxygen Therapy Equipment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Mobility
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Oxygen Therapy Equipment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Mobility
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Oxygen Therapy Equipment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Mobility
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Oxygen Therapy Equipment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Mobility
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Oxygen Therapy Equipment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Mobility
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Oxygen Therapy Equipment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Mobility
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Oxygen Therapy Equipment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Mobility
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Oxygen Therapy Equipment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Mobility
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Oxygen Therapy Equipment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Mobility
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Oxygen Therapy Equipment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Mobility
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oxygen Therapy Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Allied Healthcare Products, Inc.
    • 15.5.2. CAIRE Inc.
    • 15.5.3. DeVilbiss Healthcare
    • 15.5.4. Fisher & Paykel Healthcare Limited
    • 15.5.5. Inogen Inc.
    • 15.5.6. Invacare Corporation
    • 15.5.7. Koninklijke Philips N.V.,
    • 15.5.8. Smiths Medical, Inc.
    • 15.5.9. Taiyo Nippon Sanso Corporation
    • 15.5.10. Linde Healthcare

16. Strategic Recommendations

17. About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦